Weekly cisplatin plus capecitabine in metastatic breast cancer patients heavily pretreated with both anthracycline and taxanes. [electronic resource]
Producer: 20060105Description: 408-13 p. digitalISSN:- 0030-2414
- Anthracyclines -- therapeutic use
- Antigen-Presenting Cells -- cytology
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Breast Neoplasms -- drug therapy
- Capecitabine
- Cisplatin -- administration & dosage
- Dendritic Cells -- cytology
- Deoxycytidine -- administration & dosage
- Disease Progression
- Enzyme-Linked Immunosorbent Assay
- Flow Cytometry
- Fluorouracil -- analogs & derivatives
- Genes, Reporter
- Green Fluorescent Proteins -- metabolism
- HLA-A Antigens -- immunology
- HLA-A24 Antigen
- Humans
- Immunotherapy -- methods
- Interferon-gamma -- metabolism
- Leukocytes, Mononuclear -- metabolism
- Microscopy, Fluorescence
- Neoplasm Metastasis
- RNA, Messenger -- metabolism
- Remission Induction
- Taxoids -- therapeutic use
- Time Factors
- Transcription, Genetic
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.